News

Light-activated nanoneedles let researchers rewrite the fate of individual cells

A laser-guided nanoneedle approach brings genetic delivery down to the level of individual cells, opening new possibilities for studying how altered cells influence their surroundings.
Written byBree Foster, PhD
| 3 min read
3D rendering of cells and DNA on a blue background.

A new optoporation approach delivers genetic instructions to individual cells.

credit: istock.com/e-crow

Register for free to listen to this article
Listen with Speechify
0:00
3:00

Researchers have used light-activated silicon nanoneedles to deliver genetic material into selected individual cells, changing their behavior while leaving neighboring cells largely untouched.

The approach, developed by scientists at King's College London, could give scientists a new way to build more precise models of tissue development and disease by controlling exactly which cells receive a genetic instruction.

Published in ACS Biomaterials Science & Engineering, the study shows that porous silicon nanoneedles can concentrate laser light at the interface between the nanoneedle and a cell. This temporarily permeabilizes the cell membrane, allowing genetic cargo suspended in the surrounding medium to enter.

What could such precise control mean for disease models and drug development?

A more selective way to deliver genes

Nucleic acid delivery is already widely used to manipulate cells in research and medicine. However, most established approaches deliver genetic material to large populations of cells at once. That can be a problem when researchers want to target just a subset of cells.

One way to achieve greater spatial precision is through optoporation, which uses precisely directed light to temporarily create openings in a cell's membrane so that genetic material can enter. By controlling where the light is directed, researchers can gain greater control over where delivery occurs.

Continue reading below...
Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Application NoteAssessing immune cell killing in 3D tumor models
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Read More

That level of precision could eventually prove useful in several areas. In disease modeling, for example, researchers could manipulate selected cells within a larger population and study how changes in a small number of cells affect their neighbors and the wider tissue.

Greater precision could also be valuable for ex vivo cell therapies, where scientists modify cells outside the body before administering them to patients. These treatments often require researchers to first isolate and purify the cell population they want to engineer before modifying it. A technology capable of selectively manipulating particular cells within a mixed population could potentially reduce the number or complexity of those processing steps.

Tiny materials known as nanosensitizers can make optoporation more efficient by concentrating the effects of the light. Gold nanotubes and titanium dioxide nanostructures have both been used for this purpose. However, these materials can potentially damage DNA or cause other unwanted biological effects.

The King's College London team instead turned to porous silicon nanoneedles, a material with an established track record in nucleic acid delivery and a history of biocompatibility.

Tuning the needles for delivery

The researchers first had to work out how to make their tiny silicon needles as effective as possible at delivering cargo into cells.

By adjusting the laser conditions and changing the structure and surface chemistry of the nanoneedles, the team found that thermally carbonized porous silicon nanoneedles could reach up to 90 percent delivery efficiency under optimized conditions.

Most importantly, the researchers showed that the system could deliver functional mRNA. They introduced mRNA encoding green fluorescent protein into cells with a 72 percent delivery efficiency. Twenty-four hours later, 68 percent of the cells were producing the fluorescent protein, showing that the mRNA was successfully translated.

Changing the fate of a chosen cell

The final experiment tested whether they could program selected cells at defined locations within a larger cell population. The researchers called this “spatially resolved cell-fate engineering”.

The researchers delivered mRNA encoding SNAIL1, a transcription factor that helps drive epithelial-to-mesenchymal transition (EMT), into selected cells. EMT is an important biological process in development and wound repair, but its dysregulation has also been implicated in cancer progression and metastasis.

Following targeted delivery of SNAIL1 mRNA, the selected cells showed molecular changes consistent with an EMT-associated shift in cell state. Notably, only the cells targeted by the treatment were affected. Nearby cells remained unchanged, showing that the technique can control cell behavior with a high level of precision.

This level of control could be particularly useful for studying biological processes in which the behavior of a small number of cells has consequences for the wider tissue. Researchers could use the approach to build more precise disease models, investigate how altered cells influence their neighbors, and study how tissues develop or change over time. With further development, the same level of precision could also prove useful for selectively engineering cells for research or therapeutic applications.

However, further work is still needed before the platform can be applied to more complex biological models. The study did not include dedicated short- or long-term assessments of cell viability, and extending the approach from 2D cell cultures into organoids or other 3D tissues will present additional challenges, including light penetration and access to cells beyond the surface.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Photo of Bree Foster

    Bree Foster is a science writer at Drug Discovery News with over 5 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science. She is particularly drawn to topics around women's health, the microbiome, psychiatry, and the growing use of computational methods in drug discovery and clinical development. 

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.